Eva Tiensuu Janson

Summary

Affiliation: Uppsala University
Country: Sweden

Publications

  1. doi request reprint Nordic Guidelines 2010 for diagnosis and treatment of gastroenteropancreatic neuroendocrine tumours
    Eva Tiensuu Janson
    Department of Medical Sciences, Uppsala University, Uppsala, Sweden
    Acta Oncol 49:740-56. 2010
  2. ncbi request reprint Endocrine pancreatic tumors with glucagon hypersecretion: a retrospective study of 23 cases during 20 years
    Henrik Kindmark
    Department of Medicine Endocrine Oncology, University Hospital, Uppsala, Sweden
    Med Oncol 24:330-7. 2007
  3. doi request reprint Long-term results of surgery for small intestinal neuroendocrine tumors at a tertiary referral center
    Olov Norlén
    Department of Surgical Sciences, Uppsala University, Uppsala, Sweden
    World J Surg 36:1419-31. 2012
  4. ncbi request reprint A panel of 13 region-specific radioimmunoassays for measurements of human chromogranin B
    Mats Stridsberg
    Department of Medical Sciences, Clinical Chemistry, University Hospital, SE 75185 Uppsala, Sweden
    Regul Pept 125:193-9. 2005
  5. ncbi request reprint High-dose treatment with a long-acting somatostatin analogue in patients with advanced midgut carcinoid tumours
    Staffan V Welin
    Department of Medical Sciences, University Hospital, Uppsala, Sweden
    Eur J Endocrinol 151:107-12. 2004
  6. ncbi request reprint Temozolomide as monotherapy is effective in treatment of advanced malignant neuroendocrine tumors
    Sara Ekeblad
    Department of Medical Sciences, Uppsala University, Uppsala, Sweden
    Clin Cancer Res 13:2986-91. 2007
  7. doi request reprint Measurements of secretogranins II, III, V and proconvertases 1/3 and 2 in plasma from patients with neuroendocrine tumours
    Mats Stridsberg
    Department of Medical Sciences, Uppsala University Hospital, Uppsala, Sweden
    Regul Pept 148:95-8. 2008
  8. ncbi request reprint Treatment of neuroendocrine tumors with somatostatin analogs
    Eva Tiensuu Janson
    Department of Medical Sciences, Endocrine Oncology, Uppsala University Hospital, Uppsala S 751 85, Sweden
    Pituitary 9:249-56. 2006
  9. ncbi request reprint Differential expression of the five somatostatin receptor subtypes in human benign and malignant insulinomas - predominance of receptor subtype 4
    Guida Maria Portela-Gomes
    Department of Genetics and Pathology, Unit of Pathology, University Hospital, Uppsala, 75185, Sweden
    Endocr Pathol 18:79-85. 2007
  10. ncbi request reprint Upregulated expression of PDGF receptor beta in endocrine pancreatic tumors and metastases compared to normal endocrine pancreas
    Marie Louise Fjällskog
    Department of Oncology, University Hospital, Uppsala, Sweden
    Acta Oncol 46:741-6. 2007

Collaborators

Detail Information

Publications13

  1. doi request reprint Nordic Guidelines 2010 for diagnosis and treatment of gastroenteropancreatic neuroendocrine tumours
    Eva Tiensuu Janson
    Department of Medical Sciences, Uppsala University, Uppsala, Sweden
    Acta Oncol 49:740-56. 2010
    ..The guidelines are meant to be useful in the daily practice for clinicians handling patients with neuroendocrine tumours...
  2. ncbi request reprint Endocrine pancreatic tumors with glucagon hypersecretion: a retrospective study of 23 cases during 20 years
    Henrik Kindmark
    Department of Medicine Endocrine Oncology, University Hospital, Uppsala, Sweden
    Med Oncol 24:330-7. 2007
    ..In an attempt to assess the efficacy of diagnostic and therapeutic measures in patients with glucagonoma, a retrospective study was performed using the archives of a tertiary care center...
  3. doi request reprint Long-term results of surgery for small intestinal neuroendocrine tumors at a tertiary referral center
    Olov Norlén
    Department of Surgical Sciences, Uppsala University, Uppsala, Sweden
    World J Surg 36:1419-31. 2012
    ..Our aim was to identify prognostic factors for survival and to evaluate outcome after surgery in SI-NET patients...
  4. ncbi request reprint A panel of 13 region-specific radioimmunoassays for measurements of human chromogranin B
    Mats Stridsberg
    Department of Medical Sciences, Clinical Chemistry, University Hospital, SE 75185 Uppsala, Sweden
    Regul Pept 125:193-9. 2005
    ..Several CgB-related peptides have been identified in tissue extracts...
  5. ncbi request reprint High-dose treatment with a long-acting somatostatin analogue in patients with advanced midgut carcinoid tumours
    Staffan V Welin
    Department of Medical Sciences, University Hospital, Uppsala, Sweden
    Eur J Endocrinol 151:107-12. 2004
    ..To explore this therapeutic strategy further, we have studied the effect of a high-dose formula of octreotide, octreotide pamoate, in midgut carcinoid patients...
  6. ncbi request reprint Temozolomide as monotherapy is effective in treatment of advanced malignant neuroendocrine tumors
    Sara Ekeblad
    Department of Medical Sciences, Uppsala University, Uppsala, Sweden
    Clin Cancer Res 13:2986-91. 2007
    ..A retrospective analysis of the toxicity and efficacy of temozolomide in advanced neuroendocrine tumors...
  7. doi request reprint Measurements of secretogranins II, III, V and proconvertases 1/3 and 2 in plasma from patients with neuroendocrine tumours
    Mats Stridsberg
    Department of Medical Sciences, Uppsala University Hospital, Uppsala, Sweden
    Regul Pept 148:95-8. 2008
    ..In this study we describe generation of antibodies against SgII, SgIII, SgV and the proconvertases PC1/3 and PC2 and development of radioimmunoassays for measurements of these proteins...
  8. ncbi request reprint Treatment of neuroendocrine tumors with somatostatin analogs
    Eva Tiensuu Janson
    Department of Medical Sciences, Endocrine Oncology, Uppsala University Hospital, Uppsala S 751 85, Sweden
    Pituitary 9:249-56. 2006
    ..This possibility will be studied in future trials...
  9. ncbi request reprint Differential expression of the five somatostatin receptor subtypes in human benign and malignant insulinomas - predominance of receptor subtype 4
    Guida Maria Portela-Gomes
    Department of Genetics and Pathology, Unit of Pathology, University Hospital, Uppsala, 75185, Sweden
    Endocr Pathol 18:79-85. 2007
    ..The finding of a strong expression of sstr4 in both benign and malignant insulinomas suggests that this receptor subtype could be of importance for diagnostic and therapeutic use...
  10. ncbi request reprint Upregulated expression of PDGF receptor beta in endocrine pancreatic tumors and metastases compared to normal endocrine pancreas
    Marie Louise Fjällskog
    Department of Oncology, University Hospital, Uppsala, Sweden
    Acta Oncol 46:741-6. 2007
    ..This is also true for PDGFR beta expression in the corresponding stroma. We suggest that new therapeutic options to inhibit the growth and spread of EPTs could include targeting of PDGFR beta...
  11. ncbi request reprint Octreoscan in patients with bronchial carcinoid tumours
    Dan Granberg
    Department of Endocrine Oncology, University Hospital, Uppsala, Sweden
    Clin Endocrinol (Oxf) 59:793-9. 2003
    ..We were interested in estimating the efficacy of octreoscan for detection of the primary tumour and metastases in patients with bronchial carcinoids...
  12. doi request reprint Differentiated expression of somatostatin receptor subtypes in experimental models and clinical neuroblastoma
    Kleopatra Georgantzi
    Department of Women s and Children s Health, Uppsala University, Uppsala, Sweden
    Pediatr Blood Cancer 56:584-9. 2011
    ..The aim of this study was to investigate the expression of the different somatostatin receptors (SSTRs) in NB tumor cells that may form targets for future therapeutic development...
  13. ncbi request reprint A panel of 11 region-specific radioimmunoassays for measurements of human chromogranin A
    Mats Stridsberg
    Department of Medical Sciences, Clinical Chemistry, Uppsala University Hospital, S 751 85, Uppsala, Sweden
    Regul Pept 117:219-27. 2004
    ..Several CgA-related peptides have been identified in tissue, and many of the biological effects attributed to CgA seem to be mediated by these peptides...